Matthew E. Hardee

1.9k citations

31 papers · 1.4k indexed · h-index 17

Impact in

Genetics top 5%
- Glioma Diagnosis and Treatment
Hematology top 5%
- Erythropoietin and Anemia Treatment

Papers in ⓘ

Radiation 7
- Advanced Radiotherapy Techniques 7
Genetics 6
- Glioma Diagnosis and Treatment 5

Co-authors: David Zagzag (2 shared papers)Mark W. Dewhirst (11 shared papers)Kimberly Blackwell (5 shared papers)Murat O. Arcasoy (4 shared papers)John P. Kirkpatrick (5 shared papers)Ariel E. Marciscano (3 shared papers)Zahid N. Rabbani (6 shared papers)Mary Helen Barcellos‐Hoff (2 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (3 papers)British Journal of Cancer (2 papers)Medical Physics (2 papers)Technology in Cancer Research & Treatment (2 papers)PLoS ONE (2 papers)
Partner nations: United States South Korea Netherlands

In The Last Decade

Matthew E. Hardee

31 papers receiving 1.4k citations

Peers

Countries citing papers authored by Matthew E. Hardee

Since Specialization

Citations

This map shows the geographic impact of Matthew E. Hardee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Hardee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Hardee more than expected).

Fields of papers citing papers by Matthew E. Hardee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Hardee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Hardee. The network helps show where Matthew E. Hardee may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew E. Hardee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew E. Hardee Line = papers co-authored together Matthew E. Hardee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mechanisms of Glioma-Associated Neovascularization American Journal Of Pathology ·Matthew E. Hardee, David Zagzag	2012	346
2	Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β Cancer Research ·Matthew E. Hardee, Ariel E. Marciscano, Christina M. Medina-Ramirez, David Zagzag, Ashwatha Narayana, Scott Lonning, Mary Helen Barcellos‐Hoff	2012	190
3	Erythropoietin Biology in Cancer Clinical Cancer Research ·Matthew E. Hardee, Murat O. Arcasoy, Kimberly Blackwell, John P. Kirkpatrick, Mark W. Dewhirst	2006	168
4	Nipple Skin-Sparing Mastectomy is Feasible for Advanced Disease Annals of Surgical Oncology ·Eric C. Burdge, James C. Yuen, Matthew E. Hardee, Pranjali V. Gadgil, Chandan J. Das, Ronda Henry‐Tillman, Daniela Ochoa, Soheila Korourian, V. Suzanne Klimberg	2013	89
5	Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression PLoS ONE ·Matthew E. Hardee, Yiting Cao, Ping Fu, Xiaohong Jiang, Yulin Zhao, Zahid N. Rabbani, Željko Vujašković, Mark W. Dewhirst, Murat O. Arcasoy	2007	84
6	Merkel Cell Carcinoma: Epidemiology, Target, and Therapy Current Dermatology Reports ·Mathew P. Hughes, Matthew E. Hardee, Lynn A. Cornelius, Laura F. Hutchins, Jürgen C. Becker, Ling Gao	2014	72
7	Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis British Journal of Cancer ·Matthew E. Hardee, John P. Kirkpatrick, Shengzhou Shan, Shane A. Snyder, Z. Vujaskovic, Zahid N. Rabbani, Mark W. Dewhirst, Kimberly Blackwell	2005	52
8	Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models International Journal of Radiation OncologyBiologyPhysics ·Nathan A. Koonce, Charles M. Quick, Matthew E. Hardee, Azemat Jamshidi‐Parsian, Judith Dent, Giulio F. Paciotti, Dmitry A. Nedosekin, Ruud P.M. Dings, Robert J. Griffin	2015	49
9	Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity Molecular Cancer Therapeutics ·Matthew E. Hardee, Zahid N. Rabbani, Murat O. Arcasoy, John P. Kirkpatrick, Željko Vujašković, Mark W. Dewhirst, Kimberly Blackwell	2006	49
10	Novel Imaging Provides New Insights into Mechanisms of Oxygen Transport in Tumors Current Molecular Medicine ·Matthew E. Hardee, Mark W. Dewhirst, Nikita Agarwal, Brian S. Sorg	2009	42
11	Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification British Journal of Cancer ·Allison Betof Warner, Zahid N. Rabbani, Matthew E. Hardee, S J Kim, Gloria Broadwater, Rex C. Bentley, Shane A. Snyder, Z. Vujaskovic, Egbert Oosterwijk, Lyndsay N. Harris, Janet K. Horton, Mark W. Dewhirst, K. L. Blackwell	2012	41
12	Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors Journal of Biomedical Optics ·Brian S. Sorg, Matthew E. Hardee, Nikita Agarwal, Benjamin J. Moeller, Mark W. Dewhirst	2008	39
13	Prone Hypofractionated Whole-Breast Radiotherapy Without a Boost to the Tumor Bed: Comparable Toxicity of IMRT Versus a 3D Conformal Technique International Journal of Radiation OncologyBiologyPhysics ·Matthew E. Hardee, Shahzad Raza, S Becker, Gabor Jozsef, Stella Lymberis, Tsivia Hochman, Judith D. Goldberg, K. DeWyngaert, Silvia C. Formenti	2011	35
14	Application of Spatially Fractionated Radiation (GRID) to Helical Tomotherapy using a Novel TOMOGRID Template Technology in Cancer Research & Treatment ·Xiaomin Zhang, José Peñagarícano, Yulong Yan, Sunil Sharma, Robert J. Griffin, Matthew E. Hardee, Eun Young Han, V. Ratanatharathom	2013	27
15	Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans Radiation Oncology ·Xiaoying Liang, José Peñagarícano, Dandan Zheng, S Morrill, Xiaomin Zhang, Peter M. Corry, Robert J. Griffin, Eunyoung Han, Matthew E. Hardee, V. Ratanatharathom	2016	25
16	Squamous cell carcinoma of the prostate. PubMed ·Rena D. Malik, George R. Dakwar, Matthew E. Hardee, Nicholas J Sanfilippo, Andrew B. Rosenkrantz, Samir S. Taneja	2011	22
17	Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors Cancer Chemotherapy and Pharmacology ·Matthew E. Hardee, Rose J. Eapen, Zahid N. Rabbani, Matthew R. Dreher, Jeffrey R. Marks, Kimberly Blackwell, Mark W. Dewhirst	2008	17
18	Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia PLoS ONE ·Nathan A. Koonce, Joseph Levy, Matthew E. Hardee, Azemat Jamshidi‐Parsian, Kieng B. Vang, Sunil Sharma, James A. Raleigh, Ruud P.M. Dings, Robert J. Griffin	2015	14
19	Management of High-Risk Localized Prostate Cancer Advances in Urology ·Ariel E. Marciscano, Matthew E. Hardee, Nicholas J Sanfilippo	2011	13
20	The Effect of Darbepoetin Alfa on Growth, Oxygenation and Radioresponsiveness of a Breast Adenocarcinoma Radiation Research ·John P. Kirkpatrick, Matthew E. Hardee, Stacey A. Snyder, Catherine M. Peltz, Yulin Zhao, David M. Brizel, Mark W. Dewhirst, Kimberly Blackwell	2006	9

About Matthew E. Hardee

Matthew E. Hardee is a scholar working on Radiation, Genetics, Hematology, Cancer Research and Oncology, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (7 papers), Erythropoietin and Anemia Treatment (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Radiation Therapy and Dosimetry (5 papers), Glioma Diagnosis and Treatment (5 papers), Nanoplatforms for cancer theranostics (3 papers), Breast Cancer Treatment Studies (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Genetics (327 citations), Hematology (286 citations), Cancer Research (373 citations), Oncology (441 citations) and Radiation (97 citations). Matthew E. Hardee has collaborated with scholars based in United States, South Korea and Netherlands. Frequent co-authors include David Zagzag, Mark W. Dewhirst, Kimberly Blackwell, Murat O. Arcasoy, John P. Kirkpatrick, Ariel E. Marciscano, Zahid N. Rabbani, Mary Helen Barcellos‐Hoff, Ashwatha Narayana and Scott Lonning. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, British Journal of Cancer, Medical Physics, Technology in Cancer Research & Treatment and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact